Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

FDA approves Takeda, Protagonist drug for rare blood disorder

The FDA approved rusfertide, a new drug from Takeda and Protagonist Therapeutics to treat a rare blood disease. Rusfertide, which will be branded as Mimrylo, can now be prescribed for polycythemia vera, a disease in ...

We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.

Read the original at endpoints.news →

More in Health & Medicine

More from Friday 28 August →